1. HIV Protein Tat Induces Macrophage Dysfunction and Atherosclerosis Development in Low-Density Lipoprotein Receptor–Deficient Mice

   • Zhaojie Meng
   • Rebecca Hernandez
   • Changcheng Zhou

   Original Article 18 January 2021 Pages: 201 - 215

   

2. Effects of OP2113 on Myocardial Infarct Size and No Reflow in a Rat Myocardial Ischemia/Reperfusion Model

   • Wangde Dai
   • Nivea Dias Amoedo
   • Robert A. Kloner

   Original Article 08 February 2021 Pages: 217 - 227

   

3. The Protective Role of Bmal1-Regulated Autophagy Mediated by HDAC3/SIRT1 Pathway in Myocardial Ischemia/Reperfusion Injury of Diabetic Rats

   • Zhen Qiu
   • Hao Ming
   • Zhong-yuan Xia

   Original Article 23 February 2021 Pages: 229 - 243

   

4. Vitamin D₃ Supplementation Alleviates Left Ventricular Dysfunction in a Mouse Model of Diet-Induced Type 2 Diabetes: Potential Involvement of Cardiac Lipotoxicity Modulation

   • Clothilde Philouze
   • Jean-Charles Martin
   • Philippe Obert

   Original Article 04 March 2021 Pages: 245 - 256

   

5. Heart Rate Reduction with Ivabradine Prevents Cardiac Rupture after Myocardial Infarction in Mice

   • Masataka Ikeda
   • Tomomi Ide
   • Hiroyuki Tsutsui

   Short Communication 07 January 2021 Pages: 257 - 262

   

6. The Effect of Enhanced External Counterpulsation on Platelet Aggregation in Patients with Coronary Heart Disease

   • Yating Wang
   • Danyan Xu

   Original Article 21 January 2021 Pages: 263 - 269

   

7. Aspirin Alone Versus Dual Antiplatelet Therapy after Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis

   • Xiaoxiao Lin
   • Shuai Wang
   • Jinyu Huang

   Original Article 11 February 2021 Pages: 271 - 278

   

8. Aspirin Versus Dual Antiplatelet Therapy in Patients Undergoing Trans-Catheter Aortic Valve Implantation, Updated Meta-Analysis

   • Mohammad Alkhalil
   • Richard Edwards
   • Rajiv Das

   Short Communication 15 February 2021 Pages: 279 - 283

   

9. A 10-Year Aortic Center Experience with Hybrid Repair of Chronic “Residual” Aortic Dissection After Type A Repair

   • Marine Gaudry
   • Alizée Porto
   • Philippe Piquet

   Original Article 02 February 2021 Pages: 285 - 294

   

10. Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease—Perspective from the Veterans Affair Healthcare System

    • Xiaoming Jia
    • Michelle T. Lee
    • Salim S. Virani

    Original Article 01 February 2021 Pages: 295 - 300

    

11. LDL Cholesterol Reduction Variability with Different Types and Doses of Statins in Monotherapy or Combined with Ezetimibe. Results from the Spanish Arteriosclerosis Society Dyslipidaemia Registry

    • Elisenda Climent
    • Ana M. Bea
    • on behalf of the Dyslipidaemia Registry of the Spanish Atherosclerosis Society

    Original Article 08 February 2021 Pages: 301 - 308

    

12. A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database

    • Niti M. Patel
    • Britney A. Stottlemyer
    • Sandra L. Kane-Gill

    Original Article 18 February 2021 Pages: 309 - 322

    

13. Risk Stratification and Efficacy of Spironolactone in Patients with Heart Failure with Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial

    • Yifen Lin
    • Xiangbin Zhong
    • Xiaodong Zhuang

    Original Article 01 April 2021 Pages: 323 - 331

    

14. Efficacy and Safety of Clinically Driven Low-Dose Treatment with Direct Oral Anticoagulants in Asians with Atrial Fibrillation: a Systematic Review and Meta-analysis

    • Jillie Choi
    • Jae Eun No
    • Yun Mi Yu

    Original Article 16 March 2021 Pages: 333 - 345

    

15. Inflammation in Coronary Atherosclerosis and Its Therapeutic Implications

    • Nicholas J. Montarello
    • Mau T. Nguyen
    • Peter J. Psaltis

    Review Article 10 November 2020 Pages: 347 - 362

    

16. Research Progress on Pulmonary Arterial Hypertension and the Role of the Angiotensin Converting Enzyme 2-Angiotensin-(1–7)-Mas Axis in Pulmonary Arterial Hypertension

    • Feng Zhang
    • Aidong Chen
    • Ying Han

    Review Article 04 January 2021 Pages: 363 - 370

    

17. Effects of Angiotensin II Receptor Blockers on Ventricular Hypertrophy in Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials

    • Ye Liu
    • Kanako Teramoto
    • Kanhua Yin

    Review Article 06 January 2021 Pages: 371 - 378

    

18. Cardiovascular Adverse Events Associated with Energy Drinks in Adolescents and Young Adults

    • Samuel Lévy
    • Riccardo Cappato

    Letter to the Editor 26 February 2022 Pages: 379 - 381